Insider Trading Alert - NHI, DYN And FICO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 14, 2015, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $67.14 to $168,133,945.20.

Highlighted Stocks Traded by Insiders:

National Health Investors (NHI) - FREE Research Report

Jobe James R, who is Director at National Health Investors, bought 200 shares at $66.37 on May 14, 2015. Following this transaction, the Director owned 4,225 shares meaning that the stake was boosted by 4.97% with the 200-share transaction.

Mendelsohn D. Eric, who is EVP - Corporate Finance at National Health Investors, bought 1,500 shares at $65.77 on May 14, 2015. Following this transaction, the EVP - Corporate Finance owned 1,500 shares meaning that the stake was boosted by 100% with the 1,500-share transaction.

The shares most recently traded at $67.61, up $1.84, or 2.72% since the insider transaction. Historical insider transactions for National Health Investors go as follows:

  • 4-Week # shares bought: 398
  • 4-Week # shares sold: 5,950
  • 12-Week # shares bought: 398
  • 12-Week # shares sold: 5,950
  • 24-Week # shares bought: 398
  • 24-Week # shares sold: 5,950

The average volume for National Health Investors has been 171,200 shares per day over the past 30 days. National Health Investors has a market cap of $2.5 billion and is part of the financial sector and real estate industry. Shares are down 5.6% year-to-date as of the close of trading on Thursday.

National Health Investors Inc. is a real estate investment trust. It invests in the real estate markets of United States. The firm invests in the health care properties primarily in the long-term care and senior housing industries. The stock currently has a dividend yield of 5.2%. The company has a P/E ratio of 21.0. Currently, there is 1 analyst who rates National Health Investors a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHI - FREE

TheStreet Quant Ratings rates National Health Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full National Health Investors Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Buy-Rated Dividend Stocks In The Top 3: EPD, NHI, MMP

National Health Investors (NHI) Reaches New Lifetime High Today

Trade-Ideas: National Health Investors (NHI) Is Today's "Barbarian At The Gate" Stock

Best 3 Yielding Buy-Rated Stocks: DUK, NHI, ADC

3 Buy-Rated Dividend Stocks Taking The Lead: UBCP, UBP, NHI